Lung inflammation perturbation by engineered nanoparticles

Abstract

In recent years, the unique and diverse physicochemical properties of nanoparticles have brought about their wide use in many fields; however, it is necessary to better understand the possible human health risks caused by their release in the environment. Although the adverse health effects of nanoparticles have been proposed and are still being clarified, their effects on lung health have not been fully studied. In this review, we focus on the latest research progress on the pulmonary toxic effects of nanoparticles, and we summarized their disturbance of the pulmonary inflammatory response. First, the activation of lung inflammation by nanoparticles was reviewed. Second, we discussed how further exposure to nanoparticles aggravated the ongoing lung inflammation. Third, we summarized the inhibition of the ongoing lung inflammation by nanoparticles loaded with anti-inflammatory drugs. Forth, we introduced how the physicochemical properties of nanoparticles affect the related pulmonary inflammatory disturbance. Finally, we discussed the main gaps in current research and the challenges and countermeasures in future research.

Multifunctional Fluoropolymer‐Engineered Magnetic Nanoparticles to Facilitate Blood‐Brain Barrier Penetration and Effective Gene Silencing in Medulloblastoma

“…Therefore, this finding allowed us to speculate that FNP1 nanoparticles do not cause significant aggregation and thus reduce the potential to cause nanoparticle‐induced lung inflammation – as previously reported for a range of other nanoparticle vectors. [ 40 ] Also, degradation of the bidentate 89 Zr─O bonds of the polymer coating was observed, however, this can be explained by the stronger osteophillic properties of the 89 Zr 4+ metal cation in vivo, resulting in skeletal remineralization in active bone and joints. [ 41 ] Brant et al explain the polymer complex, in the absence of an octadentate chelating agent, has an incomplete co‐ordination sphere of the radiometal, leading to unfavorable and unspecific bone uptake of the osteophillic radiometal and is not reflective of the nanoparticle behavior.…”

Nanostructured Medical Devices: Regulatory Perspective and Current Applications

“…Nanostructured MDs, in particular through the release of nanoparticles, can lead in principle to a number of adverse health effects. Of these, lung toxicity of nanoparticles shed by such devices should be considered [11]: Pulmonary toxic ef-fects of nanoparticles and their disturbance of the pulmonary inflammatory response are being recognized as relevant problems. In vivo studies have shown that carbon-based nanoparticles, metal-based nanoparticles, oxide-based nanoparticles, and sulfide-based nanoparticles cause a pulmonary inflammatory response in mice or rats after respiratory exposure.…”